Cargando…

Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium

The purpose of our study was the obtaining, characterization and biocompatibility estimation of novel carrier systems for diclofenac. Diclofenac is a potent nonsteroidal anti-inflammatory drug with frequent gastrointestinal side effects, impairing the quality of the patient’s life. Original diclofen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pauna, Ana-Maria Raluca, Mititelu Tartau, Liliana, Bogdan, Maria, Meca, Andreea-Daniela, Popa, Gratiela Eliza, Pelin, Ana Maria, Drochioi, Cristian Ilie, Pricop, Daniela Angelica, Pavel, Liliana Lacramioara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953466/
https://www.ncbi.nlm.nih.gov/pubmed/36830989
http://dx.doi.org/10.3390/biomedicines11020453
_version_ 1784893884840542208
author Pauna, Ana-Maria Raluca
Mititelu Tartau, Liliana
Bogdan, Maria
Meca, Andreea-Daniela
Popa, Gratiela Eliza
Pelin, Ana Maria
Drochioi, Cristian Ilie
Pricop, Daniela Angelica
Pavel, Liliana Lacramioara
author_facet Pauna, Ana-Maria Raluca
Mititelu Tartau, Liliana
Bogdan, Maria
Meca, Andreea-Daniela
Popa, Gratiela Eliza
Pelin, Ana Maria
Drochioi, Cristian Ilie
Pricop, Daniela Angelica
Pavel, Liliana Lacramioara
author_sort Pauna, Ana-Maria Raluca
collection PubMed
description The purpose of our study was the obtaining, characterization and biocompatibility estimation of novel carrier systems for diclofenac. Diclofenac is a potent nonsteroidal anti-inflammatory drug with frequent gastrointestinal side effects, impairing the quality of the patient’s life. Original diclofenac-loaded micro-vesicles coated with chitosan were prepared and physico-chemical analyzed. We investigated their in vitro hemocompatibility and in vivo biocompatibility in rats. The animals were treated orally as follows: group 1 (Control): distilled water 0.3 mL/100 g body weight; Group 2 (CHIT): 0.3 mL/100 g body weight 0.5% chitosan solution; Group 3 (DCF): 15 mg/kg body weight diclofenac; Group 4 (DCF-ves): lipid vesicles loaded with diclofenac 15 mg/kg body weight. Blood samples were collected for assessing: red blood cells, hemoglobin, hematocrit and leukocyte formula. A series of specific parameters of the liver and kidney function, some markers of immune defense, as well as the activity of some enzymes involved in oxidative processes, were also investigated. At the end of the experiment, the animals were sacrificed and fragments of liver, kidney and stomach were collected for histopathological examination. No blood hemolysis was evidenced by the in vitro test with the administration of diclofenac vesicles. The animals treated with diclofenac lipid vesicles stabilized with chitosan did not display any notable differences in their hematological and biochemical profile compared to control animals. These data correlated with the histological results, which showed the absence of architectural changes in the examined tissues. Biological in vitro and in vivo evaluation revealed that the microvesicles containing diclofenac are biocompatible, with potential to be used as delivery systems to modify the drug release, thus making them an attractive candidate for biomedical applications.
format Online
Article
Text
id pubmed-9953466
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99534662023-02-25 Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium Pauna, Ana-Maria Raluca Mititelu Tartau, Liliana Bogdan, Maria Meca, Andreea-Daniela Popa, Gratiela Eliza Pelin, Ana Maria Drochioi, Cristian Ilie Pricop, Daniela Angelica Pavel, Liliana Lacramioara Biomedicines Article The purpose of our study was the obtaining, characterization and biocompatibility estimation of novel carrier systems for diclofenac. Diclofenac is a potent nonsteroidal anti-inflammatory drug with frequent gastrointestinal side effects, impairing the quality of the patient’s life. Original diclofenac-loaded micro-vesicles coated with chitosan were prepared and physico-chemical analyzed. We investigated their in vitro hemocompatibility and in vivo biocompatibility in rats. The animals were treated orally as follows: group 1 (Control): distilled water 0.3 mL/100 g body weight; Group 2 (CHIT): 0.3 mL/100 g body weight 0.5% chitosan solution; Group 3 (DCF): 15 mg/kg body weight diclofenac; Group 4 (DCF-ves): lipid vesicles loaded with diclofenac 15 mg/kg body weight. Blood samples were collected for assessing: red blood cells, hemoglobin, hematocrit and leukocyte formula. A series of specific parameters of the liver and kidney function, some markers of immune defense, as well as the activity of some enzymes involved in oxidative processes, were also investigated. At the end of the experiment, the animals were sacrificed and fragments of liver, kidney and stomach were collected for histopathological examination. No blood hemolysis was evidenced by the in vitro test with the administration of diclofenac vesicles. The animals treated with diclofenac lipid vesicles stabilized with chitosan did not display any notable differences in their hematological and biochemical profile compared to control animals. These data correlated with the histological results, which showed the absence of architectural changes in the examined tissues. Biological in vitro and in vivo evaluation revealed that the microvesicles containing diclofenac are biocompatible, with potential to be used as delivery systems to modify the drug release, thus making them an attractive candidate for biomedical applications. MDPI 2023-02-04 /pmc/articles/PMC9953466/ /pubmed/36830989 http://dx.doi.org/10.3390/biomedicines11020453 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pauna, Ana-Maria Raluca
Mititelu Tartau, Liliana
Bogdan, Maria
Meca, Andreea-Daniela
Popa, Gratiela Eliza
Pelin, Ana Maria
Drochioi, Cristian Ilie
Pricop, Daniela Angelica
Pavel, Liliana Lacramioara
Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium
title Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium
title_full Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium
title_fullStr Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium
title_full_unstemmed Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium
title_short Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium
title_sort synthesis, characterization and biocompatibility evaluation of novel chitosan lipid micro-systems for modified release of diclofenac sodium
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953466/
https://www.ncbi.nlm.nih.gov/pubmed/36830989
http://dx.doi.org/10.3390/biomedicines11020453
work_keys_str_mv AT paunaanamariaraluca synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium
AT mititelutartauliliana synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium
AT bogdanmaria synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium
AT mecaandreeadaniela synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium
AT popagratielaeliza synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium
AT pelinanamaria synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium
AT drochioicristianilie synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium
AT pricopdanielaangelica synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium
AT pavellilianalacramioara synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium